Video Experimental Relacionado
Updated: May 28, 2026
06:07
Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
Published on: October 22, 2020
¿Está iNOS comenzando a hacer humo?
1Department of Microbiology and Immunology, Weill Cornell Medical College, New York, NY 10065, USA. cnathan@med.cornell.edu
Cell
|October 18, 2011
Resumen
La inhibición de la sintetasa de óxido nítrico inducible (iNOS) puede ser una estrategia terapéutica viable para el tratamiento de la enfermedad pulmonar obstructiva crónica, una de las principales causas de muerte en todo el mundo.
Área de la Ciencia:
- Investigación biomédica en la investigación biomédica.
- Medicina Pulmonar La medicina pulmonar es el tratamiento de las enfermedades pulmonares.
- La inflamación es la inflamación.
Sus antecedentes:
- La sintasa de óxido nítrico inducible (iNOS) juega un papel importante en varias condiciones inflamatorias.
- A pesar de su participación en la inflamación, la inhibición terapéutica de iNOS aún no ha logrado el éxito.
- La enfermedad pulmonar obstructiva crónica (EPOC) es un gran problema de salud mundial y una de las principales causas de mortalidad.
Objetivo del estudio:
- Investigar el potencial de inhibir iNOS como un enfoque terapéutico para la enfermedad pulmonar obstructiva crónica (EPOC).
Principales métodos:
- El estudio realizado por Seimetz et al. (2011) presenta un caso para la orientación de iNOS en el tratamiento de la EPOC.
Principales resultados:
- La investigación sugiere un beneficio terapéutico potencial de la inhibición de iNOS en el contexto de la EPOC.
Conclusiones:
- Dirigirse a iNOS presenta una vía prometedora para desarrollar nuevos tratamientos para la enfermedad pulmonar obstructiva crónica.
Videos de Conceptos Relacionados
01:23Inhaled Medications
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:29Stimulants
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:24Pulmonary Ventilation: Inhalation
Pulmonary ventilation is a vital process that ensures the exchange of oxygen and carbon dioxide in the lungs. It refers to the movement of air into and out of the lungs, enabling the body to obtain oxygen and remove waste carbon dioxide. In this article, we will explore the intricacies of pulmonary ventilation, including its underlying principles, mechanisms, and the interplay of pressures within the respiratory system.
Boyle's law becomes particularly pertinent when examining respiratory...
Boyle's law becomes particularly pertinent when examining respiratory...